| Oct 5, 12 | Tesco falls to two month low but FTSE 100 lifted by US jobs figures | | No data |
| Oct 3, 12 | AstraZeneca gains on acquisition talk but FirstGroup loses 21% after West Coast chaos | | No data |
| Oct 1, 12 | What odds on AstraZeneca's successful reinvention? | | No data |
| Oct 1, 12 | AstraZeneca's new boss suspends share buyback scheme saving £1.4bn | | No data |
| Sep 24, 12 | Yule Catto falls as bid hopes fade but speculation returns to Sainsbury | | No data |
| Sep 24, 12 | Shire and Smith & Nephew in demand as investors seek defensive stocks | | No data |
| Sep 19, 12 | Bid talk helps FTSE move ahead, with Centrica and United Utilities among the risers | | No data |
| Sep 14, 12 | Mining shares push FTSE 100 to six month high after Fed's latest attempt to boost economy | | No data |
| Sep 14, 12 | Mining shares fill top ten FTSE risers as market surges on US Federal Reserve QE3 moves | | No data |
| Sep 6, 12 | Pension gap widens between FTSE 100 directors and employees, survey reveals | | No data |
| Aug 28, 12 | AstraZeneca appoints new chief executive | | No data |
| Aug 8, 12 | Astra Zeneca shares slip on drug trial failure | | No data |
| Jul 26, 12 | AstraZeneca sales tumble 18% in second quarter | | No data |
| Jul 25, 12 | Arm adds 8% despite Apple disappointment while FTSE flatlines | | No data |
| Jul 17, 12 | FTSE drifts lower as Bernanke speaks but BG supported by hopes for LNG business | | No data |
| Jul 17, 12 | AstraZeneca's former chief executive takes trimmed payoff of £4.6m | | No data |
| Jul 12, 12 | AstraZeneca to focus on brain disease treatments | | No data |
| Jul 2, 12 | FTSE finishes higher despite disappointing data, while Soco surges on Vietnam deal | | No data |
| Jul 2, 12 | AstraZeneca partners with Bristol-Myers to buy US group diabetes specialist Amylin for $7bn | | No data |
| Jun 28, 12 | GlaxoSmithKline dips on renewed talk of interest in US group BioMarin | | No data |
| Jun 28, 12 | AstraZeneca in demand as long term seller turns positive at Glaxo's expense | | No data |
| Jun 22, 12 | Pharma companies boosted as latest drugs approved by EU | | No data |
| Jun 19, 12 | Analysts suggest AstraZeneca should consider merger of equals with US group AbbVie | | No data |
| Jun 5, 12 | Pay consultants accused of conflict of interest | | No data |
| May 28, 12 | AstraZeneca could consider shrinking rather than expanding, says analyst | | No data |
| May 24, 12 | GlaxoSmithKline and AstraZeneca invest in antibiotic research | | No data |
| May 18, 12 | Shareholder spring is offering even more sport than usual | | No data |
| May 8, 12 | Shareholder rebellions over executive pay: timeline | | No data |
| May 4, 12 | AstraZeneca tipped for possible takeover, but FTSE 100 drops nearly 2% on eurozone and US data | | No data |
| Apr 30, 12 | Man Group leads FTSE lower | | No data |